ABT

NYSE

ABBOTT LABORATORIES

Health Care, Health Care Equipment

$107.81

close 7 Aug 2026

-17.93%

52-week change

$187.78B

market cap

$81.97

$137.49

52-week range

Expected price

$96.52 – $117.97

Current price

$107.81

Signal

Appears fairly valued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)30.20x

P/S (TTM)4.16x

P/B3.61x

EV/EBITDA (TTM)23.41x

FCF yield (TTM)3.93%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average27.83x

P/E, sector median29.65x*

Price at 5-year median P/E$107.24*

Indicated dividend yield2.34%

Forward — analyst consensus

Forward P/E (FY2026)19.54x*

Forward P/E (FY2027)17.78x

Forward PEG1.98*

Consensus EPS FY2026 (25 analysts)$5.52

EPS growth (FY2026→FY2027)9.89%

Revenue growth (FY2026)13.48%

Street view

Price target (mean)$118.42*

Target upside9.84%

Ratings (buy / hold / sell)20 / 7 / 0

FY2026 EPS revisions, 30d (up / down)19 / 2

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 31 Mar 2026, filed 29 Apr 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +5.26%10Y CAGR +14.82%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$107.81

Cash & equivalents$6.80B

Total debt$34.05B

Shares outstanding1.74B

Result

DCF price per share$82.29

Current price$107.81

Margin of safety-23.68%

PV of years 1–10$64.23B

PV of terminal value$106.34B

Equity value$143.33B

Market-implied growth+8.23%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$7.77B	$8.17B	$8.60B	$9.06B	$9.53B	$10.04B	$10.56B	$11.12B	$11.70B	$12.32B	$229.58B
PV	$7.19B	$7.01B	$6.83B	$6.66B	$6.49B	$6.32B	$6.16B	$6.01B	$5.85B	$5.71B	$106.34B

period to 31 Mar 2026, filed 29 Apr 2026, close 7 Aug 2026